BRIEF-CVS Health shares data on Gilead's Sovaldi By: Reuters: Company News September 17, 2014 at 09:05 AM EDT * Says followed 1,965 patients who began Gilead's Sovaldi to treat hepatitis C during Dec 2013 - Aug 2014 Read More >> Related Stocks: CVS Health Corp Gilead Sciences